SH2D1A
Basic information
Region (hg38): X:124227868-124373197
Previous symbols: [ "IMD5", "LYP" ]
Links
Phenotypes
GenCC
Source:
- X-linked lymphoproliferative disease due to SH2D1A deficiency (Supportive), mode of inheritance: XL
- X-linked lymphoproliferative disease due to SH2D1A deficiency (Strong), mode of inheritance: XL
- X-linked lymphoproliferative disease due to SH2D1A deficiency (Strong), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Lymphoproliferative syndrome, X-linked, 1 | XL | Allergy/Immunology/Infectious; Hematologic; Oncologic | Surveillance for EBV infections is indicated; Prompt recognition and treatment of hemophagocytic lymphohistiocytosis (with immunologic agents or rituximab in the case of EBV infection); Treatment for individuals with hypogammaglobulinemia (with IVIG) may be beneficial; Awareness of the increased risk of lymphoma may allow prompt recognition and treatment; HSCT has been described, and is indicated in many individuals | Allergy/Immunology/Infectious; Hematologic; Oncologic | 4852784; 48119; 7188959; 6283885; 1847089; 8559596; 9771704; 11133747; 17620557; 20926771; 21971331; 32374962 |
ClinVar
This is a list of variants' phenotypes submitted to
- X-linked lymphoproliferative disease due to SH2D1A deficiency (15 variants)
- not provided (2 variants)
- X-linked lymphoproliferative syndrome (2 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SH2D1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 20 | ||||
missense | 20 | 25 | ||||
nonsense | 7 | |||||
start loss | 2 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 2 | 1 | 5 | 8 | ||
non coding | 13 | 19 | 40 | |||
Total | 17 | 5 | 36 | 26 | 21 |
Variants in SH2D1A
This is a list of pathogenic ClinVar variants found in the SH2D1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-124333698-C-A | Likely benign (Jan 01, 2023) | |||
X-124333893-G-A | Likely benign (Dec 01, 2022) | |||
X-124334064-A-T | Likely benign (Apr 01, 2023) | |||
X-124335002-G-A | Likely benign (Nov 01, 2022) | |||
X-124346012-G-A | Benign (Jan 10, 2019) | |||
X-124346149-G-A | Benign (Jan 10, 2019) | |||
X-124346297-C-T | X-linked lymphoproliferative disease due to SH2D1A deficiency • Autoinflammatory syndrome | Benign (Jan 14, 2022) | ||
X-124346325-G-C | X-linked lymphoproliferative disease due to SH2D1A deficiency | Benign/Likely benign (Apr 03, 2019) | ||
X-124346396-G-A | X-linked lymphoproliferative disease due to SH2D1A deficiency | Benign (Jan 13, 2018) | ||
X-124346519-T-A | X-linked lymphoproliferative disease due to SH2D1A deficiency | Conflicting classifications of pathogenicity (Jan 01, 2023) | ||
X-124346569-T-A | X-linked lymphoproliferative disease due to SH2D1A deficiency | Benign/Likely benign (Jul 07, 2023) | ||
X-124346633-C-T | X-linked lymphoproliferative disease due to SH2D1A deficiency | Pathogenic (Oct 01, 1998) | ||
X-124346643-A-G | X-linked lymphoproliferative disease due to SH2D1A deficiency | Pathogenic (Jan 03, 2023) | ||
X-124346644-T-C | X-linked lymphoproliferative disease due to SH2D1A deficiency • Autoinflammatory syndrome | Pathogenic/Likely pathogenic (Aug 10, 2022) | ||
X-124346645-G-T | X-linked lymphoproliferative disease due to SH2D1A deficiency | Pathogenic (Aug 07, 2000) | ||
X-124346647-A-G | X-linked lymphoproliferative disease due to SH2D1A deficiency | Likely pathogenic (Sep 07, 2018) | ||
X-124346649-G-T | X-linked lymphoproliferative disease due to SH2D1A deficiency • not specified • Autoinflammatory syndrome | Conflicting classifications of pathogenicity (Dec 13, 2023) | ||
X-124346662-A-G | X-linked lymphoproliferative syndrome | Pathogenic (Apr 13, 2018) | ||
X-124346665-A-C | X-linked lymphoproliferative disease due to SH2D1A deficiency | Conflicting classifications of pathogenicity (Nov 28, 2023) | ||
X-124346681-G-A | X-linked lymphoproliferative disease due to SH2D1A deficiency | Likely benign (Feb 02, 2025) | ||
X-124346687-C-T | X-linked lymphoproliferative disease due to SH2D1A deficiency | Likely benign (Sep 10, 2023) | ||
X-124346690-C-A | not specified • X-linked lymphoproliferative disease due to SH2D1A deficiency • Inborn genetic diseases | Benign/Likely benign (Mar 28, 2024) | ||
X-124346690-C-T | not specified • X-linked lymphoproliferative disease due to SH2D1A deficiency • Holoprosencephaly 13, X-linked;Mullegama-Klein-Martinez syndrome | Benign/Likely benign (Jan 29, 2024) | ||
X-124346695-A-G | X-linked lymphoproliferative disease due to SH2D1A deficiency | Conflicting classifications of pathogenicity (Jul 08, 2023) | ||
X-124346704-T-G | Uncertain significance (Aug 01, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SH2D1A | protein_coding | protein_coding | ENST00000371139 | 4 | 26812 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.389 | 0.572 | 125214 | 0 | 1 | 125215 | 0.00000399 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.69 | 17 | 50.9 | 0.334 | 0.00000395 | 816 |
Missense in Polyphen | 6 | 25.673 | 0.23371 | 391 | ||
Synonymous | 0.260 | 19 | 20.5 | 0.927 | 0.00000178 | 253 |
Loss of Function | 1.64 | 1 | 4.93 | 0.203 | 3.84e-7 | 84 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000365 | 0.0000365 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytoplasmic adapter regulating receptors of the signaling lymphocytic activation molecule (SLAM) family such as SLAMF1, CD244, LY9, CD84, SLAMF6 and SLAMF7. In SLAM signaling seems to cooperate with SH2D1B/EAT-2. Initially it has been proposed that association with SLAMF1 prevents SLAMF1 binding to inhibitory effectors including INPP5D/SHIP1 and PTPN11/SHP-2 (PubMed:11806999). However, by simultaneous interactions, recruits FYN which subsequently phosphorylates and activates SLAMF1 (PubMed:12458214). Positively regulates CD244/2B4- and CD84- mediated natural killer (NK) cell functions. Can also promote CD48-, SLAMF6 -, LY9-, and SLAMF7-mediated NK cell activation. In the context of NK cell-mediated cytotoxicity enhances conjugate formation with target cells (By similarity). May also regulate the activity of the neurotrophin receptors NTRK1, NTRK2 and NTRK3. {ECO:0000250|UniProtKB:O88890, ECO:0000269|PubMed:11806999, ECO:0000269|PubMed:12458214, ECO:0000305|PubMed:21219180}.;
- Pathway
- Natural killer cell mediated cytotoxicity - Homo sapiens (human);Measles - Homo sapiens (human);Integrated Lung Cancer Pathway;Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System;Direct p53 effectors
(Consensus)
Recessive Scores
- pRec
- 0.453
Intolerance Scores
- loftool
- 0.413
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58
Haploinsufficiency Scores
- pHI
- 0.504
- hipred
- Y
- hipred_score
- 0.696
- ghis
- 0.551
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.801
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Low | Low | Low |
Primary Immunodeficiency | Low | Low | Low |
Cancer | Low | Low | Low |
Mouse Genome Informatics
- Gene name
- Sh2d1a
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- adaptive immune response;humoral immune response;cellular defense response;cell-cell signaling;positive regulation of signal transduction;innate immune response;positive regulation of natural killer cell mediated cytotoxicity;regulation of immune response
- Cellular component
- cytoplasm;cytosol
- Molecular function
- SH3/SH2 adaptor activity;protein binding